Subthreshold depression and cognitive impairment but not demented in stroke patients during their rehabilitation

Acta Neurologica Scandinavica
S K SaxenaG Koh

Abstract

Subthreshold depression (sD) and cognitive impairment but not demented (CIND) in stroke patients are associated with poorer rehabilitative outcomes. Their diagnosis can easily be operationalized using validated scales. The aim of the study was to ascertain the prevalence of depressive symptoms and cognitive impairment in stroke patients during three crucial stages of the rehabilitative process, viz. upon admission, upon planned discharges from rehabilitation hospitals and at 6 months post-stroke, using validated scales like the Geriatric Depression Scale and Abbreviated Mental Test (recommended by the British Geriatric Society). Their baseline risk factors were also ascertained. On admission, the prevalence of depressive symptoms and cognitive impairment was 60% and 54% respectively. The prevalence upon planned discharges and 6 months post-stroke, respectively, of depressive symptoms was 38% and 34% and that of impaired cognition was 33% and 40%. Baseline independent correlates at 6 months post-stroke depressive symptoms were: recurrent stroke (OR 3.34); on admission cognitive impairment (OR 4.78) and ADL dependence (OR 5.28). And that of cognitive impairment were: increasing age (OR 8.07); post-stroke dysphagia (OR 4.58); on a...Continue Reading

References

Oct 1, 1992·Archives of General Psychiatry·K B WellsP Camp
Oct 1, 1992·Archives of General Psychiatry·E HorwathM M Weissman
Aug 17, 1992·The Medical Journal of Australia·P L MorrisR G Robinson
Jul 1, 1990·Stroke; a Journal of Cerebral Circulation·G SantusM R Inzoli
Feb 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·M R EastwoodJ Ruderman
Jan 1, 1988·International Disability Studies·D T Wade, C Collin
Jan 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·C E SkilbeckV A Wood
Jan 1, 1981·International Rehabilitation Medicine·K AndrewsP J Laycock
Jul 1, 1995·Acta Psychiatrica Scandinavica·K C NgP T Straughan
Nov 1, 1994·Stroke; a Journal of Cerebral Circulation·P LydenJ Marler
Feb 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·T K TatemichiE Bagiella
Jul 1, 1993·Stroke; a Journal of Cerebral Circulation·M AströmK Asplund
Jan 1, 1993·The American Journal of Psychiatry·P L MorrisT R Price
Oct 1, 1996·Stroke; a Journal of Cerebral Circulation·K W MuirK R Lees
Nov 1, 1996·Age and Ageing·G KwakkelG J Lankhorst
Feb 1, 1997·International Journal of Geriatric Psychiatry·P BurvillE Stewart-Wynne
Jul 1, 1997·Stroke; a Journal of Cerebral Circulation·G E GreshamC A Trombly
Oct 24, 1997·Archives of General Psychiatry·G S AlexopoulosM Charlson
Mar 20, 1998·Stroke; a Journal of Cerebral Circulation·N HerrmannJ P Szalai
Apr 29, 1998·Stroke; a Journal of Cerebral Circulation·O M Rønning, B Guldvog
Sep 17, 1998·Cerebrovascular Diseases·T PohjasvaaraM Kaste
Nov 6, 1998·Stroke; a Journal of Cerebral Circulation·T PohjasvaaraT Erkinjuntti
Apr 22, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M KotilaM Kaste
Sep 2, 1999·Stroke; a Journal of Cerebral Circulation·M KauhanenV V Myllylä
Jan 11, 2000·The British Journal of Psychiatry : the Journal of Mental Science·G GainottiC Marra
Mar 14, 2000·International Journal of Geriatric Psychiatry·S SahadevanS P Chan
Jul 8, 2000·Stroke; a Journal of Cerebral Circulation·R BarbaT Del Ser
Sep 14, 2000·International Journal of Geriatric Psychiatry·P P LimS Sahadevan
Nov 18, 2000·American Journal of Physical Medicine & Rehabilitation·M InouyeT Kazumi
Jan 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·R StewartC Brayne
Jul 28, 2001·Acta Psychiatrica Scandinavica·M PreisigJ Angst
Feb 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Robert C Baldwin, John O'Brien
Apr 12, 2002·Neurorehabilitation and Neural Repair·F D SheltonM Reding
May 2, 2002·Journal of the American Geriatrics Society·Mehool D PatelCharles D A Wolfe
Oct 31, 2002·Cerebrovascular Diseases·T PohjasvaaraT Erkinjuntti
Jan 4, 2003·Stroke; a Journal of Cerebral Circulation·Daniel SchlegelScott E Kasner
Feb 7, 2004·Stroke; a Journal of Cerebral Circulation·Kate HardieCraig Anderson
Aug 25, 2004·The Australian and New Zealand Journal of Psychiatry·L-F LowP Sachdev
Nov 30, 2006·Psychology, Health & Medicine·Janita ChauJean Woo

❮ Previous
Next ❯

Citations

Jun 25, 2016·TheScientificWorldJournal·Mohd Faizal Mohd ZulkiflyPonnusamy Subramaniam
Jun 29, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Joost B SandersAartjan T F Beekman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.